About
Brain Therapy Devices
Areas of Focus
Categories
Surgical Device
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
714
By Phase
PHASE2: 1PHASE3: 1PHASE1: 1PHASE1/PHASE2: 3
By Status
RECRUITING: 3COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05864534Collaborator
Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
PHASE2Recruiting
25 participants
Started: Jan 31, 2024 · Completed: Aug 31, 2026
NCT05902169Lead Sponsor
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
PHASE3Recruiting
560 participants
Started: Jan 29, 2024 · Completed: Jun 30, 2028
NCT05293197Collaborator
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
PHASE1Recruiting
24 participants
Started: Feb 6, 2023 · Completed: Oct 31, 2027
NCT04528680Collaborator
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PHASE1/PHASE2Active, not recruiting
57 participants
Started: Oct 29, 2020 · Completed: Nov 30, 2025
NCT03744026Lead Sponsor
Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
PHASE1/PHASE2Completed
38 participants
Started: Feb 18, 2019 · Completed: Jun 30, 2022
Locations (1)
Headquarters
Lyon, France
Map
Loading map...